Drugs / Vaccine Candidate #1
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT07431853 | Feb 2026 → Jun 2027 expected | — | Pfizer | Recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Vaccine Candidate #1 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07431853 ↗ |
| Modality | Messenger RNA (mRNA) | “mRNA influenza vaccine candidate #1 as a single intramuscular (IM) injection on Day 1.” NCT07431853 ↗ |
| Route | Intramuscular | “mRNA influenza vaccine candidate #1 as a single intramuscular (IM) injection on Day 1.” NCT07431853 ↗ |